Duke Sued for Millions over Fraudulent Data

A lawsuit claims that Duke University and biologist Erin Potts-Kant used bad data in projects funded by dozens of government grants.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Duke UniversityFLICKR, PENSDEVILSixty grants worth some $200 million—that’s what biologist Joseph Thomas claims is affected by fraudulent data from Duke University and biologist Erin Potts-Kant, Thomas’s former supervisor, ScienceInsider and Retraction Watch reported last week (September 1). And the university may have to shell out three times that amount if Thomas’s lawsuit is successful.

The Duke case “should scare all [academic] institutions around the country,” attorney Joel Androphy of Berg & Androphy told Retraction Watch. If successful, he added, it could “open the floodgates” to other whistleblowing cases on research misconduct in academia.

Potts-Kant was arrested on charges of embezzlement (totaling more than $25,000) in March 2013. She pled guilty, received a fine and probation, and was ordered to perform community service. Following a Duke investigation, 15 of Potts-Kant’s papers were retracted, some citing “unreliable” data. Additional publications have corrections or expressions of concern.

The lawsuit filed by Thomas was unsealed by a US district court last month, according to the news report; in it, Thomas claims that other researchers at Duke were aware of the problems with Pott-Kant’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies